CDMO

Avid Bioservices Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

CDMO price

Avid Bioservices

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment CDMO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CDMO

Valuation

P/E

0.00

Sector -3.16

Industry -3.16

P/BV

0.00

Sector 1.80

Industry 1.80

P/Revenue (PSR)

Sector 2.04

Industry 2.04

EV/EBITDA

-10.46

Sector -204.34

Industry -204.34

EV/EBIT

-5.02

Sector -42.58

Industry -42.58

P/EBITDA

Sector -19.73

Industry -19.73

P/EBIT

Sector -67.09

Industry -67.09

P/Total Assets

Sector 1.06

Industry 1.06

P/Net Current Assets

0.00

Sector -9.56

Industry -9.56

P/Working Capital

0.00

Sector -93.82

Industry -93.82

EPS

-4.21

Sector -1.78

Industry -1.78

BVPS

0.70

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

9.19%

Sector 41.28%

Industry 41.28%

EBITDA Margin

-30.35%

Sector -21,198.78%

Industry -21,198.78%

EBIT Margin

-11.07%

Sector -35.28%

Industry -35.28%

Net Profit Margins

-100.00%

Sector -35.71%

Industry -35.71%

Asset Turnover

0.10

Sector 0.03

Industry 0.03

Profitability

ROE

-239.26%

Sector -61.32%

Industry -61.32%

ROA

-69.12%

Sector -54.29%

Industry -54.29%

ROIC

-17.60%

Sector -1,801.33%

Industry -1,801.33%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.30

Sector 2.91

Industry 2.91

Net Debt / EBITDA

-10.46

Sector -20.38

Industry -20.38

Net Debt / EBIT

-5.02

Sector -4.13

Industry -4.13

Net Debt / Equity

2.69

Sector -33,112.98

Industry -33,112.98

Gross Debt / Equity

3.44

Sector -0.64

Industry -0.64

Equity/Assets

0.14

Sector 0.46

Industry 0.46

Liabilities/Assets

0.86

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

7.33%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals CDMO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CDMO Avid Bioservices Inc.	$0.00	-	0.00%	0.00	0.00	-239.26%	-100.00%
PFE Pfizer Inc.	$30.41	33.97%	5.73%	39.46	2.00	4.97%	6.80%
ABBV AbbVie Inc.	$288.29	36.44%	2.31%	53.66	0.00	-%	14.76%
NVO Novo Nordisk A/S	$40.49	-13.45%	4.66%	9.73	5.17	60.28%	35.32%
MRK Merck & Co. Inc.	$145.20	73.83%	2.27%	116.34	8.79	6.97%	4.77%
AZN AstraZeneca PLC	$185.11	15.21%	1.73%	22.38	5.77	27.27%	16.95%
BMY Bristol-Myers Squibb Company	$62.63	41.99%	5.06%	13.78	5.44	44.06%	18.47%
ZTS Zoetis Inc.	$83.43	-40.99%	2.60%	12.71	10.64	64.91%	27.69%
AMGN Amgen Inc.	$464.48	60.80%	2.13%	28.86	21.58	91.47%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$973.63	52.20%	0.41%	21.68	2.96	14.04%	27.86%
HALO Halozyme Therapeutics Inc.	$130.37	99.98%	0.00%	37.10	106.90	173.67%	24.86%
MCK McKesson Corporation	$1,008.67	24.93%	0.34%	25.96	-30.85	-168.45%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$536.30	26.02%	0.00%	32.22	7.01	23.54%	35.00%
CAH Cardinal Health Inc.	$255.97	35.45%	0.81%	34.74	-21.86	-63.98%	0.67%
ARGX argenx SE	$883.95	8.00%	0.00%	13.26	-	-%	25.42%
HRMY Harmony Biosciences Holdings Inc.	$38.00	33.01%	0.00%	12.39	2.25	20.46%	18.88%
BIIB Biogen Inc.	$251.87	63.27%	0.00%	45.08	2.00	4.58%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CDMO - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/15/2018	04/02/2018	0.65600000

ABOUT Avid Bioservices

Avid Bioservices Inc.

Average Investor10 user rating

4.0 (0 people)

United States

45 years

Founded: 1981

1988

Time since IPO - 38 years

227

Employees

Avid Bioservices Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $44.81 million.

The company employs approximately 227 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Avid Bioservices Inc. reported $159.61 million in revenue, generating net income of $-269.14 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CDMO.

Market cap

Net worth

$44.81 million

$44,810,000.00

Assets

$323.48 million

$323,480,000.00

Total Shares Outstanding

64.00 million

64,000,000

Average Daily Trading Volume

$1.26 million

$1,259,058.12

Sector

Health Care

Industry

Biotechnology

CDMO

CDMO revenue and profits

Financial Results CDMO

DRAG THE FRAME TO SEE MORE DATA

CDMO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$1,008.67 23,56% (12M)

P/E

25.96

0.34%

ROE

-168.45%

P/BV

-30.85

CAH - Cardinal Health

$255.97 35,84% (12M)

P/E

34.74

0.81%

ROE

-63.98%

P/BV

-21.86

ABBV - AbbVie

$288.29 40,35% (12M)

P/E

53.66

2.31%

ROE

P/BV

0.00

MRK - Merck & Co.

$145.20 81,18% (12M)

P/E

116.34

2.27%

ROE

6.97%

P/BV

8.79

AZN - AstraZeneca

$185.11 14,78% (12M)

P/E

22.38

1.73%

ROE

27.27%

P/BV

5.77

PFE - Pfizer

$30.41 33,92% (12M)

P/E

39.46

5.73%

ROE

4.97%

P/BV

2.00

BMY - Bristol-Myers Squibb

$62.63 42,14% (12M)

P/E

13.78

5.06%

ROE

44.06%

P/BV

5.44

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$1,008.67 23,56% (12 M)

P/L

25.96

0.34%

ROE

-168.45%

P/VP

-30.85

CAH - Cardinal Health

$255.97 35,84% (12 M)

P/L

34.74

0.81%

ROE

-63.98%

P/VP

-21.86

ABBV - AbbVie

$288.29 40,35% (12 M)

P/L

53.66

2.31%

ROE

P/VP

0.00

MRK - Merck & Co.

$145.20 81,18% (12 M)

P/L

116.34

2.27%

ROE

6.97%

P/VP

8.79

AZN - AstraZeneca

$185.11 14,78% (12 M)

P/L

22.38

1.73%

ROE

27.27%

P/VP

5.77

PFE - Pfizer

$30.41 33,92% (12 M)

P/L

39.46

5.73%

ROE

4.97%

P/VP

2.00

BMY - Bristol-Myers Squibb

$62.63 42,14% (12 M)

P/L

13.78

5.06%

ROE

44.06%

P/VP

5.44

Frequently Asked Questions

What is the price of Avid Bioservices (CDMO) today?

The current price of Avid Bioservices (CDMO) is $0.00. The stock began the year trading around $0.00 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Avid Bioservices (CDMO) pay dividends?

Avid Bioservices (CDMO) did not pay dividends over the past year.

Is Avid Bioservices (CDMO) a good investment?

Avid Bioservices (CDMO) is currently trading at $0.00 with a P/E ratio of 0.00. This represents a -1,090% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Avid Bioservices (CDMO) stock?

You can buy Avid Bioservices (CDMO) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol CDMO and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Avid Bioservices (CDMO) yield today?

Over the past month, Avid Bioservices (CDMO) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Avid Bioservices (CDMO) today at the current price of $0.00 your total investment would be $0.00.

Based on historical performance, the investment would have grown to approximately:

$0.00 after 1 year
$0.00 after 5 years
$0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CDMO

Avid Bioservices Inc.

Asset unavailable for trading

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CDMO

Target price created!

Delete target price?

Your Target Price strategy deserves unlimited alerts

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING CDMO WITH OTHER STOCKS

type

Ex - Dividend Date

payment date

value

ABOUT Avid Bioservices

Avid Bioservices Inc.

United States

45 years

1988

227

PROFIT X PRICE CDMO

Financial Results CDMO

CDMO cash flow

Asset, Revenue and Profit Growth - CDMO

CDMO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions